A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target
Page 1 of 1
A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target
Jon Moulton Wed Jan 24, 2018 12:15 pm
Ibhazehiebo K, Gavrilovici C, de la Hoz CL, Ma S-C, Rehak R, Kaushik G, Meza Santoscoy PL, Scott L, Nath N, Kim D-Y, Rho JM, Kurrasch DM. A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target. Brain 2018;awx364. doi:10.1093/brain/awx364
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» A platform for discovery of functional cell-penetrating peptides for efficient multi-cargo intracellular delivery
» Morpholino-based correction of hypomorphic ZAP70 mutation in an adult with combined immunodeficiency
» Gene Interference with Morpholinos in a Gold Nanoparticle-Based Delivery Platform in Rat PC12 Cells
» Zebrafish lipid metabolism: from mediating early patterning to the metabolism of dietary fat and cholesterol
» Near-Infrared-Light-Based Nano-Platform Boosts Endosomal Escape and Controls Gene Knockdown in Vivo
» Morpholino-based correction of hypomorphic ZAP70 mutation in an adult with combined immunodeficiency
» Gene Interference with Morpholinos in a Gold Nanoparticle-Based Delivery Platform in Rat PC12 Cells
» Zebrafish lipid metabolism: from mediating early patterning to the metabolism of dietary fat and cholesterol
» Near-Infrared-Light-Based Nano-Platform Boosts Endosomal Escape and Controls Gene Knockdown in Vivo
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum